AzTrials
AzTrials

Apical PeriodontitisNCT06843850

Lesion Healing After Regenerative Endodontic Treatment

A study testing regenerative endodontics in people with Apical Periodontitis, run by TC Erciyes University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Endodontics involves various therapeutic interventions for diagnosing, preventing, and managing pulpal and periradicular pathologies. Root canal treatment, a widely performed procedure, involves removing necrotic pulp tissue and replacing it with a root-filling material, but it limits the tooth's immune defense and… Read more about this study

Who is it for?
Ages 9 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Apical Periodontitis
What is being tested?
regenerative endodontics
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2024to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The included patients were healthy (Category: American Society of Anesthesiologists class 1). This study included the necrotic, deeply carious mandibular molars of patients born between 2009 and 2015. Preoperative periapical films of the relevant teeth were evaluated, and teeth determined as Stages 2 and 3 according to the Cvek classification were included in the current study [27].

Who cannot join

  • Patients were excluded if they had a systemic disease or were on systemic corticoste roid therapy, patients reported bruxism or clenching, took analgesics or other drugs that might alter their pain during the last 12 h preoperatively, or had a history of allergic reac tions to any of the medications or materials used. Patients with a tooth with severely curved root canals, vertical root fracture, coronal perforation, calcification or more signifi cant than Grade I mobility, or pocket depth greater than 5 mm were also excluded.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Erciyes University

    Kayseri

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Effect of Different Irrigation Solutions Used in Regenerative Endodontic Treatment of Necrotic Open Apexed Lower Molar Teeth on Lesion Healing-Randomized Clinical Trial

Endodontics involves various therapeutic interventions for diagnosing, preventing, and managing pulpal and periradicular pathologies. Root canal treatment, a widely performed procedure, involves removing necrotic pulp tissue and replacing it with a root-filling material, but it limits the tooth's immune defense and regenerative capacity. In immature permanent teeth, pulpal damage can lead to incomplete root formation, increasing the risk of fractures. To address these challenges, regenerative endodontic procedures (REPs) promote tissue regeneration within the root canal using tissue engineering principles.

Despite high success rates, REPs lack a standardized irrigation protocol. Current guidelines recommend using 17% EDTA after low-concentration NaOCl to reduce cytotoxicity and release bioactive molecules. Citric acid has shown promise in in vitro studies as an alternative chelating agent, but direct comparisons with EDTA in clinical settings remain limited. This study aims to bridge this gap by evaluating the long-term effects of EDTA and citric acid on clinical symptoms and lesion healing in REPs.

Read the detailed description

Endodontics includes various therapeutic interventions to diagnose, prevent, and manage pulpal and periradicular pathologies, including endodontic infections (Duncan et al., 2023). Root canal treatment is a widely performed procedure globally (Leveque et al., 2024) for cases of irreversible pulpitis or pulp necrosis, facilitating the healing of periapical tissues and preventing apical periodontitis. This treatment involves the removal of necrotic pulp tissue and its replacement with a root-filling material. However, despite its effectiveness, conventional root canal therapy is inherently limited in biological activity, as it compromises the tooth's immune defense, vascularization, and regenerative capacity.

Pulpal damage in immature permanent teeth can result from caries, traumatic injuries, or developmental anomalies, leading to pulp necrosis and incomplete root formation (Palma et al., 2017). In such cases, conventional endodontic approaches pose significant challenges due to the high risk of root fractures and extrusion of filling materials, given the presence of thin dentinal walls and open apices (Shah et al., 2008). Furthermore, the lack of adequate root maturation compromises the tooth's structural integrity, increasing its susceptibility to fracture (Bracks et al., 2019). Consequently, novel biomaterials and regenerative strategies have been introduced to address these challenges.

Regenerative endodontic procedures (REPs) have emerged as biologically driven treatments that offer the potential to restore functional dentition by promoting tissue regeneration within the root canal space of immature necrotic teeth (Shamszadeh et al., 2019, Kim et al., 2018). These procedures leverage the principles of tissue engineering, which are fundamental to their long-term efficacy, incorporating key elements such as stem cells, three-dimensional scaffolds, signaling molecules, and a sterile microenvironment (Bracks et al., 2019).

Clinical studies utilizing REPs have yielded promising outcomes, demonstrating high survival and success rates ranging from 95% to 100% (Arslan et al., 2019, Alobaid et al., 2014). Additionally, these studies have reported increased root length, thickness, and apical closure (Shah et al., 2008, Torabinejad and Faras, 2012). Despite these favorable findings, a standardized irrigation regimen for REPs has yet to be established (Shamszadeh et al., 2019). Current clinical guidelines from the American Association of Endodontists (AAo, 2016) recommend the application of 17% ethylenediaminetetraacetic acid (EDTA) following the use of low-concentration sodium hypochlorite (NaOCl).

The inclusion of EDTA is crucial in mitigating NaOCl-induced cytotoxicity while facilitating the liberation of bioactive molecules from dentin (Chae et al., 2018). Moreover, dentin conditioning with EDTA removes the smear layer, thereby exposing growth factors sequestered within the dentin matrix (Bracks et al., 2019). The utilization of chelating agents as a final conditioning step in REP protocols is instrumental in enhancing dentin demineralization, thereby promoting the release of bioactive molecules that can foster the migration, adhesion, and differentiation of stem cells from the periapical region. While EDTA remains the benchmark agent for dentin conditioning in REPs, alternative chelating agents, such as citric acid, have been primarily assessed in vitro and have demonstrated potential to improve cellular responses and growth factor release (Ivica et al., 2019).

A recent systematic review examining both clinical and laboratory-based studies indicated that citric acid enhances smear layer removal and induces a greater release of TGF-β1 compared to other solutions (Gómez-Delgado et al., 2023). However, another systematic review and meta-analysis reported that 10% citric acid resulted in lower TGF-β1 release compared to 10% EDTA (Tavares et al., 2021). However, these prior studies did not directly compare citric acid with EDTA, the standard conditioning agent in REPs, nor were their findings exclusively focused on regenerative endodontic procedures. Consequently, further research is warranted to establish the optimal chelating agent for dentin conditioning in REPs. Since no previous studies have directly compared the effectiveness of EDTA and citric acid in assessing long-term clinical symptoms or their impact on lesion healing, the present study aims to fill this gap and provide more comprehensive evidence on the optimal chelating agent for regenerative endodontic procedures.

Being tested
regenerative endodontics
Keywords
irrigation solution, lesion healing, regenerative endodontics
Medical subject headings
Periapical Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • regenerative endodonticsDevice

    The effect of different irrigation solutions on lesion healing in regenerative endodontics will be compared.

Study groups in NCT06843850
Study groupRoleWhat they receive
EDTAExperimentalNot described
Receives: Device: regenerative endodontics
Citric acidExperimentalNot described
Receives: Device: regenerative endodontics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the effects of different irrigation solutions used in regenerative endodontics on lesion healing using surveys

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start1 Jan 2024
  3. Primary completion1 Mar 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06843850
Sponsor's protocol ID
2024/302
Status last verified
Feb 2025
First submitted
31 Jan 2025
Last updated
25 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing regenerative endodontics in people with Apical Periodontitis, run by TC Erciyes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the effects of different irrigation solutions used in regenerative endodontics on lesion healing using surveys (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in